Surface Pharmaceuticals
We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency and clear, differentiated clinical advantages.
All edits
Surface Pharmaceuticals
505(b)(2) drugs
We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency and clear, differentiated clinical advantages.
Surface Ophthalmics, Inc. is a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases. We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency, and a clear, differentiated clinical advantages. Our current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity®, a patented delivery vehicle. We are led by an experienced and proven management team and board of directors with over 80 years of ophthalmology related professional experience.
July 21, 2021
May 6, 2021
March 31, 2021
Surface Pharmaceuticals
505(b)(2) drugs
Surface Pharmaceuticals
Company
Surface Pharmaceuticals
Company
Surface Pharmaceuticals
We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency and clear, differentiated clinical advantages.
Find more companies like Surface Pharmaceuticals
